Pylopass™ Bioactive Ingredient against Helicobacter pylori
The pathogenic stomach bacterium Helicobacter pylori can lead to gastritis and stomach ulcers. In our microbial strain collection we have identified a probiotic Lactobacillus strain which acts highly specific against Helicobacter pylori. The product is available under the Trademark Pylopass™.
This website is an overview for professionals of published scientific information on Pylopass™ and published scientific information on clinical and nutritional trials with Pylopass™. No claims are made herein for any particular consumer product, and any use of these statements is the sole responsibility of the user based on his / her independent evaluation. The republication of the statements made herein is prohibited. It is always important to ensure that final communications to the consumer on food and food supplement products containing Pylopass™ comply with the applicable regulations in the regions / countries where the products are marketed.
The recommended use for Pylopass™ is as a nutrient or dietary supplement. The intended use of products containing Pylopass™ may be subject to different laws and regulations. The statements on this website have not been evaluated by the U.S. Food and Drug Administration. Pylopass™ is not intended for use to diagnose, treat, cure or prevent any disease. The information contained herein is believed to be correct and corresponds to the latest state of scientific and technical knowledge. However, no warranty is made, either expressed or implied, regarding its accuracy or the results to be obtained from the use of such information and no warranty is expressed or implied concerning the use of these products. The buyer assumes all risks of use and / or handling. No statement is intended or should be construed as a recommendation to infringe any existing patent.